CVS Health (CVS) Tops Q2 EPS by 2c; Boosts FY16 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
CVS Health Reports Second Quarter Results
August 2, 2016 6:55 AM EDTWOONSOCKET, R.I., Aug. 2, 2016 /PRNewswire/ --
Second Quarter Year-over-year Highlights:
Net revenues increased 17.6% to $43.7 billion GAAP operating profit increased 3.9% to $2.4 billion; operating profit excluding acquisition-related transaction and integration costs increased 6.5% GAAP diluted EPS decreased from $1.12 to $0.86, primarily driven by a loss on early extinguishment of debt and acquisition-related integration costs Adjusted EPS increased 8.3% to $1.32Year-to-date Highlights:
Cash flow from operations of $4.0 billion Generated free cash flow of $2.9 billion2016... More
